Kenvue Inc. (NYSE:KVUE) Receives Consensus Recommendation of “Hold” from Analysts

Kenvue Inc. (NYSE:KVUE) has received a consensus rating of “Hold” from the sixteen research firms that are presently covering the firm, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $19.3333.

Several equities research analysts have recently issued reports on KVUE shares. UBS Group lowered their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Barclays reduced their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Citigroup reduced their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Finally, Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th.

Kenvue Trading Up 1.0%

KVUE stock opened at $19.15 on Friday. The company’s 50-day simple moving average is $17.66 and its 200-day simple moving average is $17.63. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. Kenvue has a 52-week low of $14.02 and a 52-week high of $22.87. The firm has a market cap of $36.76 billion, a P/E ratio of 22.52, a PEG ratio of 1.45 and a beta of 0.54.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same period in the prior year, the company posted $0.24 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, equities analysts forecast that Kenvue will post 1.16 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is 97.65%.

Insider Buying and Selling at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.59% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in Kenvue in the 4th quarter valued at about $756,862,000. Independent Franchise Partners LLP raised its holdings in Kenvue by 56.3% in the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company’s stock valued at $830,527,000 after acquiring an additional 17,343,785 shares during the last quarter. Sculptor Capital LP raised its holdings in Kenvue by 1,023.5% in the 4th quarter. Sculptor Capital LP now owns 12,886,328 shares of the company’s stock valued at $222,289,000 after acquiring an additional 11,739,328 shares during the last quarter. Capitolis Liquid Global Markets LLC raised its holdings in Kenvue by 1,116.8% in the 4th quarter. Capitolis Liquid Global Markets LLC now owns 10,950,999 shares of the company’s stock valued at $188,905,000 after acquiring an additional 10,050,999 shares during the last quarter. Finally, Cibc World Markets Corp acquired a new stake in Kenvue in the 4th quarter valued at about $162,193,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.